A detailed history of Smartleaf Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 284 shares of CRL stock, worth $55,598. This represents 0.01% of its overall portfolio holdings.

Number of Shares
284
Previous 203 39.9%
Holding current value
$55,598
Previous $42.1 Million 33.8%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $15,224 - $19,868
81 Added 39.9%
284 $56.3 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $5,985 - $7,793
29 Added 16.67%
203 $42.1 Million
Q1 2024

Oct 07, 2024

SELL
$203.52 - $273.43 $5,902 - $7,929
-29 Reduced 14.29%
174 $46.9 Million
Q1 2024

May 02, 2024

BUY
$203.52 - $273.43 $6,919 - $9,296
34 Added 24.29%
174 $34.4 Million
Q4 2023

Feb 12, 2024

BUY
$164.52 - $238.84 $23,032 - $33,437
140 New
140 $33.4 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.